arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

COMPASS Pathways Plc

CMPS Health Care Biotechnology: Pharmaceutical Preparations
$13.20
▼ -0.5% Today
as of Sep 4, 16:47 ET
Last 30 days +17.75% Jul 27 → Sep 04
$10.53 $11.70 $12.87 $14.03 $15.20 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$13.17
High
$13.38
Low
$13.05
Volume
$788,494
Avg Vol
$3M
Mkt Cap
$1.9B
P/E (TTM)
—
Beta
—
52w High
$15.40
52w Low
$4.82
Div Yield
—
Shares Out
$136M

Recent Press Releases & News last 60 days · 25 items

Sep 3 · 20:30 PR Business Wire
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 2 · 10:30 PR Business Wire
Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree
Sep 1 · 10:30 PR Business Wire
Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$4.82
$15
79% of range
Avg surprise (last 3)
+12.3%
Avg reaction (last 2)
+8.8%
100% positive
Latest IV / EM
63%
EM ±9.8% · $13 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-620.00$-465.07$-310.15$-155.22$-0.30 Actual $-0.57Actual $-620.00Actual $-0.67Actual $-0.55Actual $-0.56Actual $-0.56Actual $-0.44Est $-0.47Actual $-0.38Est $-0.37Actual $-1.44Actual $-0.30Est $-0.45Actual $-1.88 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-254M$-166M$-79M$8M$96M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.88 — — — — financials
Wed May 13, 2026Mar/2026 $-0.30 $-0.45 +33.3% +31.8% +17.0% earnings
Tue Sep 30, 2025Sep 2025 $-1.44 — — — — financials
Thu Jul 31, 2025Jun/2025 $-0.38 $-0.37 -2.7% — — earnings
Thu May 8, 2025Mar/2025 $-0.44 $-0.47 +6.4% — +0.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.56 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.56 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.55 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.67 — — — — financials
Fri Jun 30, 2023Jun 2023 $-620.00 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.57 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-52M$-43M—$-41M$-43M$-50M—$-48M
Net income$-254M$91M—$-138M$-38M$-18M—$-39M
EPS (diluted)$-1.88$-0.30—$-1.44$-0.41$-0.24—$-0.56

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$433M$466M$150M$186M$222M$260M$165M$207M
Inventory————————
Total current assets$476M$511M$191M$242M$276M$305M$201M$234M
Total assets$505M$532M$210M$256M$294M$319M$214M$247M
Long-term debt$51M$50M$14M$19M$23M$22M$25M$28M
Total liabilities$420M$205M$263M$218M$131M$124M$59M$54M
Total equity$85M$327M$-53M$38M$163M$195M$155M$193M

Implied volatility — last 90 days

57%77%96%116%136% Jun 07 — IV 113% · EM ±15.7%Jun 08 — IV 98% · EM ±12.9%Jun 09 — IV 122% · EM ±15.3%Jun 10 — IV 94% · EM ±11.1%Jun 11 — IV 95% · EM ±10.5%Jun 12 — IV 89% · EM ±9.1%Jun 15 — IV 121% · EM ±8.8%Jun 16 — IV 136% · EM ±8.0%Jun 17 — IV 89% · EM ±3.7%Jun 19 — IV 101% · EM ±22.3%Jun 22 — IV 102% · EM ±21.4%Jun 23 — IV 95% · EM ±19.4%Jun 24 — IV 99% · EM ±19.9%Jun 25 — IV 100% · EM ±19.6%Jun 26 — IV 99% · EM ±19.0%Jun 29 — IV 95% · EM ±16.9%Jun 30 — IV 85% · EM ±14.6%Jul 01 — IV 97% · EM ±16.1%Jul 02 — IV 101% · EM ±16.3%Jul 03 — IV 106% · EM ±16.5%Jul 06 — IV 80% · EM ±11.1%Jul 07 — IV 77% · EM ±10.2%Jul 08 — IV 87% · EM ±10.9%Jul 09 — IV 85% · EM ±10.0%Jul 10 — IV 86% · EM ±9.5%Jul 13 — IV 106% · EM ±8.8%Jul 14 — IV 96% · EM ±6.9%Jul 15 — IV 133% · EM ±7.8%Jul 16 — IV 122% · EM ±5.1%Jul 20 — IV 93% · EM ±22.1%Jul 21 — IV 105% · EM ±24.4%Jul 22 — IV 94% · EM ±21.5%Jul 23 — IV 122% · EM ±27.5%Jul 24 — IV 97% · EM ±21.5%Jul 27 — IV 97% · EM ±20.3%Jul 28 — IV 97% · EM ±19.9%Jul 29 — IV 106% · EM ±21.3%Jul 30 — IV 108% · EM ±21.2%Jul 31 — IV 119% · EM ±22.8%Aug 03 — IV 105% · EM ±18.7%Aug 04 — IV 95% · EM ±16.4%Aug 05 — IV 77% · EM ±12.9%Aug 06 — IV 80% · EM ±12.9%Aug 07 — IV 78% · EM ±12.2%Aug 10 — IV 59% · EM ±8.2%Aug 11 — IV 58% · EM ±7.6%Aug 12 — IV 64% · EM ±8.1%Aug 13 — IV 87% · EM ±10.3%Aug 14 — IV 77% · EM ±8.6%Aug 17 — IV 81% · EM ±6.7%Aug 18 — IV 76% · EM ±5.5%Aug 19 — IV 109% · EM ±6.4%Aug 20 — IV 94% · EM ±3.9%Aug 24 — IV 66% · EM ±13.8%Aug 25 — IV 75% · EM ±15.3%Aug 26 — IV 68% · EM ±13.6%Aug 27 — IV 69% · EM ±13.5%Aug 28 — IV 65% · EM ±12.4%Aug 31 — IV 72% · EM ±12.8%Sep 01 — IV 73% · EM ±12.6%Sep 02 — IV 69% · EM ±11.5%Sep 03 — IV 65% · EM ±10.5%Sep 04 — IV 63% · EM ±9.8%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in